According to the research report titled ‘Global Atopic Dermatitis Treatment Market Size study, by Product (Corticosteroids, Calcineurin Inhibitors, Immunosuppressants, Biologic Therapy, PDE-4 Inhibitor, Antibiotics, Antihistamines, Emollients) by Indication (Topical, Oral, Injectable) by end use industries (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores, Mail Order Pharmacies, Dermatology Clinics) and Regional Forecasts 2022-2028’, available with MarketStudyReport, global atopic dermatitis treatment market is anticipated to expand at a healthy CAGR during 2022-2028.

Increasing R&D activities in the healthcare vertical, and rising prevalence of dermatological skin conditions are the major growth stimulants for global atopic dermatitis treatment market.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/5065434/

For the unversed, atopic dermatitis (AD) is a widely prevalent chronic inflammatory skin condition that usually affects neck, face (cheeks), arms, and legs. It usually spreads to the groin areas. This condition affects people of all ages, including infants and elderly.  

Furthermore, rising disposable income of individuals, and growing healthcare spending are expected to augment industry outlook in the coming years.

However, high cost of atopic dermatitis treatments, and dearth of reimbursement policies may impede market growth during the stipulated timeframe.

Based on product terrain, the industry is branched into emollients, antihistamines, antibiotics, PDE-4 inhibitor, biologic therapy, immunosuppressants, calcineurin inhibitors, and corticosteroids. In terms of indication, the market is divided into injectable, oral, and topical. On the basis of end use industries, worldwide atopic dermatitis treatment market is segregated into dermatology clinics, mail order pharmacies, drug stores, online pharmacies, retail, pharmacies, and hospital pharmacies.

Regionally, North America market is showcasing notable growth at present, owing to rising prevalence of skin problems, and the presence of leading participants in the region.

Meanwhile, Asia Pacific industry is poised to witness a healthy CAGR over the analysis timeframe, on the back of improving healthcare infrastructure, and rising prevalence of skin illnesses among the elderly population in the region.

Regeneron Pharmaceuticals, Inc., Anacor Pharmaceuticals, Inc., Astellas Pharma, Inc., Meda Pharmaceuticals Ltd., Bayer AG, Bristol Myers Squibb Company, Novartis AG, Allergan plc, Galderma S.A., and Sanofi S.A. are the leading players in global atopic dermatitis treatment market.